Apotex announces expansion of licensing agreement with Formosa Pharmaceuticals to Mexico for commercialization of clobetasol propionate ophthalmic suspension for the treatment of inflammation and pain
MEXICO CITY, May 6, 2025 /CNW/ - Apotex Inc. (referred to as "Apotex" or "the Company") today announced it has entered into an exclusive licensing agreement with Formosa Pharmaceuticals ("Formosa", 6838.TW), for exclusive rights in Mexico for the commercialization of clobetasol propionate ophthalmic suspension, 0.05% (APP13007), a patented innovative medicine for the treatment of inflammation and pain following ocular surgery, upon regulatory approval.
Apotex Inc. Logo (CNW Group/Apotex Inc.)
APP13007 was approved by the U.S. Food and Drug Administration (FDA) in 2024. APP13007's active ingredient is the corticosteroid clobetasol propionate, and it is derived from Formosa Pharma's proprietary APNT® nanoparticle formulation platform. This novel formulation proved statistically and clinically superior to its matching placebo in Phase 3 trials in the United States (p<0.001).
This license agreement for the Mexican market adds to Apotex's existing exclusive rights to this product in Canada.
"At Apotex, we are committed to delivering access to medicines and health products, and unlocking new possibilities for patients through partnerships. We are pleased to bring access to APP13007 (clobetasol propionate ophthalmic suspension, 0.05%) to the Mexican market upon regulatory approval. Our agreement with Formosa Pharmaceuticals further demonstrates Apotex's leading position as partner of choice in the Americas for pharmaceutical licensing and product acquisitions as we continue to execute our Journey of Heath growth strategy," said Alok Kanti, President, Apotex International.
"Having started our journey together in 2024, Formosa Pharma is pleased to expand the partnership with Apotex to include the Mexico territory," said Erick Co, President and CEO of Formosa Pharmaceuticals. "Our experience with Apotex's Canadian team underscored their commitment to branded and differentiated ophthalmology products, giving us full confidence that APP13007 will reach ophthalmologists and patients in Mexico as soon as possible."
About Apotex Inc.
Apotex is a Canadian-based global health company. We improve everyday access to affordable, innovative medicines and health products for millions of people worldwide, with a broad portfolio of generic, biosimilar, innovative branded pharmaceuticals and consumer health products. Headquartered in Toronto, with regional offices globally, including in the United States, Mexico and India, we are the largest Canadian-based pharmaceutical company and a health partner of choice for the Americas for pharmaceutical licensing and product acquisitions. Learn more about us at www.apotex.com.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Bloomberg
an hour ago
- Bloomberg
US and Mexico Near Deal to Cut Steel Duties and Cap Imports
The US and Mexico are closing in on a deal that would remove President Donald Trump's 50% tariffs on steel imports up to a certain volume, according to people familiar with the matter, a revamp of a similar deal between the trade partners during his first term. Trump hasn't been directly involved in the negotiations and would need to sign off on any deal. The talks are being led by Commerce Secretary Howard Lutnick, according to the people, who asked not to be identified as the discussions are private.
New York Post
an hour ago
- New York Post
World Bank agrees with Trump's trade complaints, urges countries to lower tariffs on US
The World Bank on Tuesday agreed with President Trump's complaint that foreign countries engage in unfair trade practices with the US and urged the nations to ease their tariffs on American exports. Top economists at the international institution, which helps finance low and middle-income countries, acknowledged that many nations do not provide reciprocal trade access to the US. 'This [situation] could not be sustained indefinitely,' the World Bank's chief economist, Indermit Gill, said during a news briefing, the Washington Post reported. 3 President Trump has long groused that US trading partners engage in unfair practices. REUTERS Gill said the World Bank has had to sharply lower its global growth forecasts because of Trump's blizzard of tariffs to try to help right the situation and amid the ongoing uncertainty over global trade. But he contended that Trump's actions were merely a response to uneven trade access between other countries and the US. Other experts at the World Bank concurred with that assessment and indicated that Europe, Japan and China should all take steps to reduce trade barriers on the US, while calling for an across-the-board rollback on tariffs on all sides. 3 World Bank's chief economist, Indermit Gill, acknowledged Tuesday that several top US trade partners have had uneven trade practices. Bloomberg via Getty Images The World Bank's updated economic forecast downgraded growth expectations for the US in 2025 from its 2.3% projection in January down to 1.4%. If that prediction comes true, it will be the lowest annual growth rate in US gross domestic product since the Great Recession, not counting the COVID-19 pandemic. The institution's forecast for China meanwhile remained steady at 4.5%, while it said global growth will slow down 0.4 percentage points to 2.3%. But there's a risk of further decline, and global growth could plunge to 1.8% if trade issues persist, the World Bank warned. 3 Trump has been particularly keen on overhauling trade relations with China's president, Xi Jinping. POOL/AFP via Getty Images 'After a succession of adverse shocks in recent years, the global economy is facing another substantial headwind, with increased trade tension and heightened policy uncertainty,' the international financial institution wrote in its new forecast. 'Against the backdrop of a deteriorating global environment, growth forecasts for 2025 have been downgraded.' Trump has imposed a 10% baseline tariff rate on virtually every country, 30% duties on imports from China and Hong Kong. 30% duties on imports from China and Hong Kong, a 25% rate on imports from Canada and Mexico that aren't subject to the US-Mexico-Canada Agreement and 25% on foreign steel and aluminum. The Congressional Budget Office has estimated that if all those tariffs implemented by May 13 were left in place, it would generate about $2.8 trillion in revenue over a 10-year period. Trump has also given countries a deadline of July 8 to cut lightning trade arrangements or else face an onslaught of his customized 'Liberation Day' tariffs.
Chicago Tribune
2 hours ago
- Chicago Tribune
This month could test buyers' hunger for new vehicles as non-tariffed inventories dry up
Consumers' hunger for new vehicles persisted in May, but affordability concerns could cool sales this month as dealerships start running short on cars and SUVs delivered ahead of President Donald Trump's 25% tariffs. Ford Motor Co.'s U.S. sales increased 16% year-over-year last month. Hyundai Motor Co.'s grew 8%, while Kia Corp.'s rose 5%. Subaru Corp. and Mazda Motor Corp., however, did report declines of 10% and 19%, respectively. General Motors Co. and Stellantis NV will report second-quarter sales next month. Spring typically marks a surge in vehicle sales, as tax returns hit bank accounts and the weather warms up. But consumer sentiment has plunged to some of its lowest levels in decades amid frequently changing rules on tariffs, and concerns that vehicle prices could climb later this year have led some consumers to pull forward their purchases. S&P Global Mobility forecasted May sales up 2% compared to a year ago, but predicted sales were slowing to a seasonally adjusted annual rate of 15.7 million vehicles, down from 17.6 million from March to April. 'Consumer confidence is down, but the sales are not,' said Stephanie Brinley, associate director of research and analysis at S&P's AutoIntelligence. 'It doesn't usually work that way.' With inventories down and non-tariffed models increasingly eaten up, the 'affordability bullet has not come through yet. There's a little bit of wait-and-see for what automakers really do,' Brinley added, noting June could start revealing the direction companies choose to take. Some have given consumers confidence that they can wait a bit. Ford, through the July 4 weekend, is offering its customers thousands of dollars per vehicle in discounts typically reserved for its employees, though in early May, it did increase by up to $2,000 the price of its Mexico-built vehicles because of tariffs. Stellantis — the parent of Chrysler, Dodge, Jeep, Ram and other brands — is offering a similar employee discount program, which it has extended through June. Volkswagen AG has said it will hold to its current manufacturer's suggested retail prices through June. GM CEO Mary Barra has said the automaker doesn't expect major price increases. But imports are expected to slow, which will mean less availability of vehicles and encourage price increases, Charlie Chesbrough, senior economist at dealer digital services provider Cox Automotive Inc., said in a May forecast. 'As more tariffed products replace existing inventory over the summer,' he said, 'prices are expected to be pushed higher, leading to slower sales in the coming months.' Some dealers are already noticing some wariness. 'I haven't seen people this cautious since before, or during, the early stages of COVID,' said Jim Walen, the owner of Stellantis and Hyundai showrooms in Seattle. The ports in Seattle look 'empty,' he said. Major layoffs in Washington by Microsoft Corp. haven't helped business either. Stellantis' employee discount program, however, is a boon: 'Anytime you can affect the transaction price, it's a good thing.' Meanwhile, some dealers are going to pull back over revenue concerns, Walen said, but he's taking a different approach: 'We're very aggressive. We stock a lot, we're part of the community, we advertise a lot.' Some pull-ahead sales still seem to be occurring over tariff concerns, but other shoppers are dropping out of the market altogether, said Ivan Drury, director of insights at auto information website Inc. It may still be too early to determine if the circumstances will affect vehicle segments, but for now, there appears to be limited downgrading, as some customers would rather hold off than get a vehicle without certain features. There are also wide-ranging views on tariffs, how they work and the impact they will have, he added: 'Not everybody's on the same page.' There, however, are some trends. More consumers bought out their leases in May than in April, rather than leasing again. That could be a sign customers are seeking to limit increases to their monthly payments, but it also means they're stepping out of the market, Drury said. He added that inventory is declining, but there's still too much stock — more than 2.5 million vehicles are on dealer lots — to see substantial price increases. 'The last time when we had people really get hit with price increases, where it took them back, was when we were down to 1 million units,' Drury said. 'And that's where you start to see that crossover between consumers getting a deal versus consumers just dealing and saying, 'OK, fine, I'll pay MSRP. I'll pay above.' ' The share of electric vehicles in the market was forecasted to continue slipping. EV share was about 7% in March and April, and S&P was predicting it would be 6.8% in May. Ford EV sales last month were down by a quarter, driven by decreases in the F-150 Lightning pickup and Transit commercial van. Trump has pulled federal funding for EV charging infrastructure and directed his administration to reevaluate greenhouse gas tailpipe emission regulations and incentives that could be construed as an 'EV mandate.' The U.S. Senate last month also removed a waiver that enabled California and a contingent of states to enforce stricter zero-emission requirements on passenger vehicle sales. The result is an uncertain policy environment around EVs. 'They've been trending a little bit down the whole year,' Brinley said. 'It may be some people looking for an EV in January bought, expecting the incentives to go away, but they're not afraid of that anymore.' Rhett Ricart, who has eight new-vehicle storefronts for brands from Ford and Chevrolet to Nissan and Mitsubishi in and near Columbus, Ohio, said tariffs and policy changes are on the minds of EV buyers, but he otherwise describes sales as normal. 'A possible tariff scare people had doesn't seem to exist,' Ricart said, adding about expectations that Trump or the judicial system will offer some clarity on import taxes: 'For any jitteriness, we will hopefully find out if the tariffs stick soon.'
